Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rutin and Vitamin C in MASLD
NCT07310407Phase 2Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rutin in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Ain Shams University. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
rutin
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on NCT07310407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07310407.